Prestige Consumer Healthcare Inc. filings document material events for an operating consumer healthcare company, including 8-K disclosures on quarterly and year-to-date operating results, financial condition and Regulation FD investor presentations. The filings also cover material agreements, capital-structure matters, governance topics and shareholder voting matters tied to the company’s public-company reporting.
These records frame Prestige’s disclosures around its portfolio of over-the-counter healthcare brands, retail distribution markets, and product or regulatory matters when they are material to the business.
Schedule 13G/A disclosure by Ariel Investments, LLC reports beneficial ownership of 2,202,327 shares of Prestige Consumer Healthcare common stock, representing 4.5% of the class. Ariel states it has sole voting power over 1,950,287 shares and sole dispositive power over 2,202,327 shares. The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Ariel notes its adviser clients have rights to dividends or sale proceeds on these securities and that no client has an economic interest exceeding 5%.